These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 66687)

  • 1. Hormonal status in prostatic disease.
    Frick J; Bartsch G
    Prog Clin Biol Res; 1976; 6():143-58. PubMed ID: 66687
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of testosterone, FSH and LH on plasma in patients with prostatic adenoma and carcinoma before and after different hormonal treatments].
    Garcia de la Peña E; Ramos F; Horcajada C; Cifuentes Delatte L; Vivanco F
    Rev Clin Esp; 1978 Jan; 148(1):19-23. PubMed ID: 76325
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hormone determinations in andrology].
    Frick J
    Andrologia; 1980; 12(3):211-8. PubMed ID: 6778255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
    Cochran RC; Ewing LL; Niswender GD
    Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of prostate growth.
    Coffey DS; Isaacs JT
    Urology; 1981 Mar; 17(Suppl 3):17-24. PubMed ID: 6163242
    [No Abstract]   [Full Text] [Related]  

  • 6. Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer.
    Hsing AW; Comstock GW
    Cancer Epidemiol Biomarkers Prev; 1993; 2(1):27-32. PubMed ID: 8420607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The influence of spironolactone on the concentration of gonadotrophins and gonadal hormones in prostatic hypertrophy (author's transl)].
    Zgliczynski S; Baranowska B; Szymanowski J
    J Urol (Paris); 1981; 87(9):635-8. PubMed ID: 6174646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormonal disturbances in men with a prostatic adenoma (author's transl)].
    Baranowska B; Zgliczynski S; Szymanowski J
    J Urol (Paris); 1980; 86(7):551-8. PubMed ID: 6161196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormonal environment and antiandrogenic treatment in benign prostatic hypertrophy].
    Katayama T; Umeda K; Kazama T
    Hinyokika Kiyo; 1986 Nov; 32(11):1584-9. PubMed ID: 2435122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hormonal changes in carcinoma of the prostate].
    Rodrigues-Netto Júnior N; Da Silva RP; Hernández AJ
    Rev Paul Med; 1979; 94(1-2):24-6. PubMed ID: 120973
    [No Abstract]   [Full Text] [Related]  

  • 11. Testosterone levels in benign prostatic hypertrophy and prostate cancer.
    Mearini L; Costantini E; Zucchi A; Mearini E; Bini V; Cottini E; Porena M
    Urol Int; 2008; 80(2):134-40. PubMed ID: 18362481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the endocrine manifestations of hepatic cirrhosis.
    Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
    Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment with D-Trp-6-LHRH. Plasma levels and gonadotropic response].
    Lahlou N; Duchier J; Feinstein MC; Mauvernay RY; Roger M; Schally AV
    Pathol Biol (Paris); 1984 Oct; 32(8):906-8. PubMed ID: 6209605
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hormonal status of patients with uterine cancer during surgical treatment].
    Musina RKh; Kiseleva NS; Modnikov OP
    Vopr Onkol; 1987; 33(8):99-102. PubMed ID: 2820150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of benign prostatic hyperplasia with the preparation Gentos].
    Pecherskiĭ AV; Aleksandrov VP; Mazurov VI; Kniaz'kin IV; Zeziulin PN; Nikolaeva EV
    Urologiia; 2000; (5):16-7. PubMed ID: 11392216
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of radical prostatectomy on serum hormone levels.
    Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
    J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma steroid and protein hormone concentrations in patients with benign prostatic hypertrophy and in normal men.
    Ortega E; Ruiz E; Mendoza MC; Martin-Andres A; Osorio C
    Experientia; 1979 Jun; 35(6):844-5. PubMed ID: 89045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interdependence between hormonal disorders, stage of development and degree of malignancy of prostatic cancer. 1].
    Szymanowski J; Baranowska B; Niewiadomska A; Wysocki M; Kobuszewska-Faryna M; Zgliczynski S
    J Urol (Paris); 1983; 89(8):597-600. PubMed ID: 6677708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of serum testosterone-estradiol-binding globulin, follicular stimulating hormone, luteinizing hormone, estradiol, progesterone, and testosterone levels in women associated with aging].
    Kamatsuki S
    Igaku Kenkyu; 1982 Nov; 52(5):243-55. PubMed ID: 6821181
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormones and the pathophysiology of fibrocystic mastopathy: elevated luteinizing hormone levels.
    Golinger RC; Krebs J; Fisher ER; Danowski TS
    Surgery; 1978 Aug; 84(2):212-5. PubMed ID: 684613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.